Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers
about
Cerebrospinal fluid biomarkers of Alzheimer’s diseaseToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseasePathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activationDiet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.Gaps in Aging Research as it Applies to Rheumatologic Clinical Care.History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress.Multimarker screening of oxidative stress in aging.Obesity, age, and oxidative stress in middle-aged and older women.Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis.Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.Oxidative Stress and Its Clinical Applications in DementiaAmbient air pollution and neurotoxicity on brain structure: Evidence from women's health initiative memory studyUnusual kinetic isotope effects of deuterium reinforced polyunsaturated fatty acids in tocopherol-mediated free radical chain oxidationsMajor metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.Markers of oxidant stress that are clinically relevant in aging and age-related diseaseThe association of serum trans-nonachlor levels with atherosclerosis.Age-Related Decrease in Heat Shock 70-kDa Protein 8 in Cerebrospinal Fluid Is Associated with Increased Oxidative StressCerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies.Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.Analysis of eicosanoid oxidation products in Alzheimer brain by LC-MS with uniformly 13C-labeled internal standards.Oxidant/Antioxidant Imbalance in Alzheimer's Disease: Therapeutic and Diagnostic Prospects.The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging.
P2860
Q22252572-74742703-C256-4E15-9835-2777E6F6109CQ24595802-7C5442B9-1897-475A-9979-779FBB478CBAQ26864770-F82499FD-CF48-44EB-83B6-60F20389919DQ30052936-20DBF48E-242C-49E4-8FFF-6874F3EC6B72Q30240678-72629848-2E97-4B4C-80AD-D85F6E289585Q33462295-3EB36B6D-FFB0-447F-B109-FB0825A361A3Q34014251-36C7557C-0F25-4AC8-AFC5-FAB9B9DB67AAQ34987129-B21B8977-60F7-4E82-8C67-12617E72AF16Q35143061-F5E37F3E-9C07-4339-A04F-3CFE274F9416Q35542811-31ED1BEA-6186-4CF4-A58C-6A72A091F616Q35623258-43083758-B349-49FD-902C-8159EC753358Q35987458-55839022-3874-41C7-BC17-ABF8A1B25F64Q36082929-85D4C716-650A-4D8B-82EF-CEA5EA89CA9EQ36094027-C486E908-DCDC-4E66-B72E-73E8D43BD1AEQ36879018-9F74071D-946A-4C38-9457-77677C7A9CAFQ36992739-154EE9E5-503E-493D-A259-16DFEAE4E4E9Q37124348-692EAB78-8E7E-4827-BC6E-3B5324DA206EQ37524486-5B5BF6CF-3A8E-4BB6-B42A-F9E345A9E4ECQ38836837-7205BD80-C7A0-42A7-8506-1B183D8F7015Q48541060-FE9A7AC1-2150-447C-B88D-287CB0D436BBQ52373518-7A4066F0-E2F2-441B-881C-84164AF3B757Q52595131-F2807954-5400-406B-93FE-53385BEF02F2Q54878401-7A605317-A75C-48AB-9F4B-1F8A905C85F1
P2860
Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Increased cerebrospinal fluid ...... se as identified by biomarkers
@en
type
label
Increased cerebrospinal fluid ...... se as identified by biomarkers
@en
prefLabel
Increased cerebrospinal fluid ...... se as identified by biomarkers
@en
P2093
P2860
P921
P1476
Increased cerebrospinal fluid ...... se as identified by biomarkers
@en
P2093
Angela M Wilson
Douglas Galasko
Elaine R Peskind
Kathleen S Montine
Thomas J Montine
P2860
P2888
P356
10.1007/S12017-010-8126-6
P50
P577
2010-07-15T00:00:00Z